Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.0309 | 76 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.09902 | 76 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.24416 | 77 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.59588 | 79 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.20406 | 77 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.0663 | 77 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.37749 | 70 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.76457 | 74 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.06741 | 76 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.65291 | 80 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.17129 | 77 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.31408 | 77 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.86622 | 74 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.37025 | 78 |